CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- 8-K Event Other events
- 4 Grant or award Director acquired 31,200 shares (grant or award)
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Shareholder vote results · Other events
- 4 Open-market sale Director sold 6,000 shares at an average $351.67 ($2,110,018)
- 8-K Event Other events
- 4 Open-market sale President, COO & GM China sold 3,398 shares at an average $352.54 ($1,197,917)
- 4 Open-market sale CFO & Chief Strategy Officer sold 650 shares at $354.16 ($230,203)
- 4 Open-market sale Global Head of R&D sold 656 shares at $354.26 ($232,392)
- 4 Open-market sale CMO, Hematology sold 603 shares at $351.55 ($211,986)
- 4 Gift Director gave 7,400 shares (gift)
- 8-K Event Other events
- 4 Gift Director gave 69,000 shares (gift)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Other events
- 8-K Event Results of operations · Other events
- 4 Insider Changes in Ownership
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Other events
Page 36 of 64 · 1,278 filings